This company may still be operating, however this listing is no longer active. Find out why through their latest events.
MedMen Enterprises Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on MedMen Enterprises's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
n/a
Return on equity
n/a
Net Margin
n/a
Last Earnings Update
25 Mar 2023
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How MedMen Enterprises makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:MMNF.Q Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
25 Mar 23
120
-143
75
0
24 Dec 22
128
-140
84
0
24 Sep 22
134
-129
97
0
25 Jun 22
141
-150
112
0
26 Mar 22
146
-95
124
0
25 Dec 21
142
-89
122
0
25 Sep 21
134
-118
113
0
26 Jun 21
132
-97
110
0
27 Mar 21
126
-220
120
0
26 Dec 20
138
-221
140
0
26 Sep 20
151
-177
174
0
27 Jun 20
155
-177
203
0
28 Mar 20
161
-44
218
0
28 Dec 19
148
-51
241
0
28 Sep 19
138
-76
256
0
29 Jun 19
120
-68
267
0
30 Mar 19
103
-89
280
0
29 Dec 18
86
-81
233
0
30 Sep 18
59
-75
170
0
30 Jun 18
40
-68
105
0
31 Mar 18
21
-42
38
0
31 Dec 17
7
-28
24
0
30 Sep 17
4
-19
16
0
30 Jun 17
3
-15
12
0
Quality Earnings: Insufficient data to determine if MMNF.Q has high quality earnings.
Growing Profit Margin: Insufficient data to determine if MMNF.Q's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MMNF.Q's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare MMNF.Q's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if MMNF.Q's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: MMNF.Q has a negative Return on Equity (0%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/04/03 07:23
End of Day Share Price
2026/04/01 00:00
Earnings
2023/03/25
Annual Earnings
2022/06/25
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedMen Enterprises Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.